146 related articles for article (PubMed ID: 18044149)
1. [Clinical significance of biomarkers in diagnosis of metabolic bone diseases].
Suzuki Y
Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2151-8. PubMed ID: 18044149
[No Abstract] [Full Text] [Related]
2. [Clinical usefulness of bone turnover markers with the treatment of osteoporosis].
Miura M
Clin Calcium; 2014 Mar; 24(3):367-76. PubMed ID: 24576933
[TBL] [Abstract][Full Text] [Related]
3. [Prediction by early change of bone metabolic markers of the efficacy of anti-osteoporotic drugs on bone mass in osteoporotic patients].
Inaba M
Clin Calcium; 2014 Mar; 24(3):379-84. PubMed ID: 24576934
[TBL] [Abstract][Full Text] [Related]
4. News on biomarkers in CKD-MBD.
Mazzaferro S; Tartaglione L; Rotondi S; Bover J; Goldsmith D; Pasquali M
Semin Nephrol; 2014 Nov; 34(6):598-611. PubMed ID: 25498379
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
6. Circulating biochemical markers of bone remodeling in uremic patients.
Ureña P; De Vernejoul MC
Kidney Int; 1999 Jun; 55(6):2141-56. PubMed ID: 10354264
[TBL] [Abstract][Full Text] [Related]
7. Changes in biochemical parameters of bone turnover and bone mineral density in post-pregnancy osteoporosis.
Honjo S; Mizunuma H
Am J Obstet Gynecol; 2001 Jul; 185(1):246-7. PubMed ID: 11483939
[TBL] [Abstract][Full Text] [Related]
8. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2009 Aug; 19(8):1075-82. PubMed ID: 19638690
[TBL] [Abstract][Full Text] [Related]
10. Using biochemical bone markers.
Chapman B
CAP Today; 1997 Feb; 11(2):1, 30-2, 36. PubMed ID: 10166427
[No Abstract] [Full Text] [Related]
11. Short-term variability in biomarkers of bone metabolism in sheep.
Sousa CP; de Azevedo JT; Reis RL; Gomes ME; Dias IR
Lab Anim (NY); 2014 Jan; 43(1):21-6. PubMed ID: 24356018
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of bone turnover after a short period of steroid therapy in elderly men.
Paglia F; Dionisi S; De Geronimo S; Rosso R; Romagnoli E; Raejntroph N; Ragno A; Celi M; Pepe J; D'Erasmo E; Minisola S
Clin Chem; 2001; 47(7):1314-6. PubMed ID: 11427468
[No Abstract] [Full Text] [Related]
13. Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
Terpos E; Heath DJ; Rahemtulla A; Zervas K; Chantry A; Anagnostopoulos A; Pouli A; Katodritou E; Verrou E; Vervessou EC; Dimopoulos MA; Croucher PI
Br J Haematol; 2006 Dec; 135(5):688-92. PubMed ID: 17107351
[TBL] [Abstract][Full Text] [Related]
14. [Metabolic markers of bone and clinical use].
Miki T; Naka H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():221-6. PubMed ID: 18161110
[No Abstract] [Full Text] [Related]
15. [Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab].
Tatekoshi A; Sato T; Ibata S; Hashimoto A; Kamihara Y; Horiguchi H; Ono K; Takada K; Iyama S; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2014 Nov; 55(11):2271-6. PubMed ID: 25501406
[TBL] [Abstract][Full Text] [Related]
16. [Bone metabolic marker for osteoporosis].
Shidara K; Inaba M
Nihon Rinsho; 2009 May; 67(5):927-31. PubMed ID: 19432111
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mass and bone turnover following distal forearm fracture.
Ingle BM; Hay SM; Bottjer HM; Eastell R
Osteoporos Int; 1999; 10(5):399-407. PubMed ID: 10591838
[TBL] [Abstract][Full Text] [Related]
18. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
[TBL] [Abstract][Full Text] [Related]
19. [The significance of bone biochemical markers and its application for clinics].
Nishijima R; Kamimiya F; Horiuchi T
Nihon Rinsho; 2004 Feb; 62 Suppl 2():333-8. PubMed ID: 15035147
[No Abstract] [Full Text] [Related]
20. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
Avbersek-Luznik I; Balon BP; Rus I; Marc J
Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
